article thumbnail

Machine learning’s growing importance in researching cells

Drug Target Review

Life sciences is fundamentally governed by large, complicated, and chaotic datasets with difficult to model interactions. Those in life sciences have relied on statistical modelling, predictive algorithms, and empirically derived data for decades to build on the insight of earlier generations of scientists, and to refine techniques.

Research 116
article thumbnail

Expanding Your Assay Specificity: Cisbio Joins PerkinElmer

PerkinElmer

Following the announcement that PerkinElmer has acquired Cisbio Bioassays , here is a little more information about the exciting opportunities this brings to life sciences researchers. The company notably developed a proprietary HTRF ® technology which is a type of TR-FRET assay used in Life Sciences.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genetic variant identification: unveiling the power of STING-seq

Drug Target Review

Co-led by Dr Sanjana, the research study combines CRISPR gene editing and single-cell sequencing to identify causal genetic variants and enhance our understanding of the noncoding genome. Published in Science , the study offers new possibilities for identifying therapeutic targets in genetically influenced diseases.

article thumbnail

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

Alta Sciences

This is Altasciences’ third purpose-built laboratory.

article thumbnail

Axol Bioscience Strengthens Commercial Leadership Team With Key Appointments

The Pharma Data

CAMBRIDGE, England–( BUSINESS WIRE )– Axol Bioscience , a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Ross Wheatcroft as the Global Strategic Accounts Manager.

article thumbnail

Separating the Hype from the Hyperbole Surrounding FDORA’s Alternatives to Animal Testing under the FD&C Act

FDA Law Blog: Drug Discovery

While this hype may be warranted in some respects—a 60-year old legal provision has now been amended to acknowledge that the science of drug development is advancing—the change is mostly symbolic and is likely to take many years before we see it have a measurable impact. FDORA § 3209(a)(2).

article thumbnail

An industry leader’s perspective on the complexity of scientific data

Drug Target Review

Data-driven discovery As with many early-stage biotech companies, Five Alarm Bio is highly data-driven, producing vast amounts of experimental data through cell-based assays and phenotypic screening. cited 2024 Oct 17]. Raminderpal is currently the Global Head of AI and GenAI Practice at 20/15 Visioneers.